Literature DB >> 32658731

Effects of Deep Brain Stimulation on Postural Control in Parkinson's Disease.

Mitesh Patel1, Maria H Nilsson2, Stig Rehncrona3, Fredrik Tjernström4, Måns Magnusson4, Rolf Johansson5, Per-Anders Fransson4.   

Abstract

The standard approach to the evaluation of tremor in medical practice is subjective scoring. The objective of this study was to show that signal processing of physiological data, that are known to be altered by tremor in Parkinson's disease (PD), can quantify the postural dynamics and the effects of DBS. We measured postural control and its capacity to adapt to balance perturbations with a force platform and perturbed balance by altering visual feedback and using pseudo-random binary sequence perturbations (PRBS) of different durations. Our signal processing involved converting the postural control data into spectral power with Fast-Fourier Transformation across a wide bandwidth and then subdividing this into three bands (0-4 Hz, 4-7 Hz and 7-25 Hz). We quantified the amount of power in each bandwidth. From 25 eligible participants, 10 PD participants (9 males, mean age 63.8 years) fulfilled the inclusion criteria; idiopathic PD responsive to l-Dopa; >1 year use of bilateral STN stimulation. Seventeen controls (9 males, mean age 71.2 years) were studied for comparison. Participants with PD were assessed after overnight withdrawal of anti-PD medications. Postural control was measured with a force platform during quiet stance (35 s) and during PRBS calf muscle vibration that perturbed stance (200 s). Tests were performed with eyes open and eyes closed and with DBS ON and DBS OFF. The balance perturbation period was divided into five sequential 35-s periods to assess the subject's ability to address postural imbalance using adaptation. The signal processing analyses revealed that DBS did not significantly change the dynamics of postural control in the 0-4 Hz spectral power but the device reduced the use of spectral power >4 Hz; a finding that was present in both anteroposterior and lateral directions, during vibration, and more so in eyes open tests. Visual feedback, which usually improves postural stability, was less effective in participants with PD with DBS OFF across all postural sway frequencies during quiet stance and during balance perturbations. The expected adaptation of postural control was found in healthy participants between the first and last balance perturbation period. However, adaptation was almost abolished across all spectral frequencies in both the anteroposterior and lateral directions, with both eyes open and eyes closed and DBS ON and OFF in participants with PD. To conclude, this study revealed that DBS altered the spectral frequency dynamics of postural control in participants through a reduction of the power used >4 Hz. Moreover, DBS tended to increase the stabilizing effect of vision across all spectral bands. However, the signal processing analyses also revealed that DBS was not able to restore adaptive motor control abilities in PD.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Parkinson's disease; Postural control; Spectral analysis

Mesh:

Substances:

Year:  2020        PMID: 32658731     DOI: 10.1016/j.compbiomed.2020.103828

Source DB:  PubMed          Journal:  Comput Biol Med        ISSN: 0010-4825            Impact factor:   4.589


  2 in total

1.  Strategic alterations of posture are delayed in Parkinson's disease patients during deep brain stimulation.

Authors:  Mitesh Patel; Maria H Nilsson; Stig Rehncrona; Fredrik Tjernström; Måns Magnusson; Rolf Johansson; Per-Anders Fransson
Journal:  Sci Rep       Date:  2021-12-07       Impact factor: 4.379

2.  Postural Sway in Parkinson's Disease and Multiple Sclerosis Patients During Tasks With Different Complexity.

Authors:  Elke Warmerdam; Maike Schumacher; Thorben Beyer; Patrik Theodor Nerdal; Linda Schebesta; Klarissa H Stürner; Kirsten E Zeuner; Clint Hansen; Walter Maetzler
Journal:  Front Neurol       Date:  2022-03-29       Impact factor: 4.003

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.